If you’re being treated for primary hypothyroidism but are still experiencing symptoms, you might consider enrolling in the AVANTI Study of an investigational medication.
Have you been diagnosed with primary hypothyroidism for at least 12 months
Have you been on continuous thyroid replacement therapy with an FDA approved dose of Synthroid or Levothyroxine for at least 12 months, and at a stable dose for at least 3 month and a TSH in the last year you could qualify this study. are you still having symptoms?
New thyroid study now enrolling, for more information call:
Debbie Clark at 901-448-2676, or email her at dmclark@uthsc.edu